[NIOSH] National Disease Surveillance Program

Forms and Documents

Document Name	Status
Form 0920-0009 Att D-4_Acute Flaccid Myelitis Form and Instruction	Modified
Form 0920-0009 Att D-3_Reye Syndrome Form and Instruction	Modified
Form 0920-0009 Att D2_Kawasaki Syndrome Form and Instruction	Modified
Form 0920-0009 Att D-1_CJD Form and Instruction	Modified
H. PIA CJD, Reye Syndrome, Kawasaki.pdf Supplementary Document	2026-01-20
G. PIA AFM.pdf Supplementary Document	2026-01-20
F. Standardized Case Definition for AFM.pdf Supplementary Document	2026-01-20
E. Non-research determination.pdf Supplementary Document	2026-01-20
C. Surveillance Summaries.docx Supplementary Document	2026-01-20
B. Published 60-Day Federal Register 0920-0009.pdf Supplementary Document	2026-01-20
A. Authorizing legislation.pdf Supplementary Document	2026-01-20
H. PIA CJD, Reye Syndrome, Kawasaki.pdf Supplementary Document	2022-08-24
G. PIA AFM.pdf Supplementary Document	2022-08-24
F. Standardized Case Definition for AFM.pdf Supplementary Document	2022-08-24
E. Non-research determination.pdf Supplementary Document	2022-08-24
C. Surveillance Summaries.docx Supplementary Document	2022-08-24
B. Published 60-day NDSP.pdf Supplementary Document	2022-08-24
A. Authorizing legislation.docx Supplementary Document	2022-08-24
SSB 0009 - 2025 Revision.docx Supporting Statement B	2026-01-20
SSA 0009 - 2025 Revision.docx Supporting Statement A	2026-01-20

IC Document Collections

IC ID	Document Title	Status
219461	Att D-4_Acute Flaccid Myelitis Form and Instruction	Modified
219460	Att D-3_Reye Syndrome Form and Instruction	Modified
219459	Att D2_Kawasaki Syndrome Form and Instruction	Modified
219458	Att D-1_CJD Form and Instruction	Modified

ICR Details

OMB Control No: 0920-0009	ICR Reference No: 202601-0920-004
Status: Received in OIRA	Previous ICR Reference No: 202208-0920-011
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-0009
Title: [NIOSH] National Disease Surveillance Program
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 01/21/2026

	Requested	Previously Approved
Expiration Date	36 Months From Approved	01/31/2026
Responses	181	461
Time Burden (Hours)	78	98
Cost Burden (Dollars)	0	0

---

Abstract: The purpose of this data collection is to collect disease specific surveillance reports of rare, uncommon, or infrequent diseases. The data will be used to determine the prevalence of diseases dangerous to public health. The data will also be used for planning and evaluating effective programs for prevention and control of infectious diseases. Disease incidence is needed to study present and emerging disease problems. Case data will be transmitted to CDC electronically or hard copy from State and Local Health Departments. This Revision includes reduction of burden hours due to fewer respondents expected. Updates to the format for collecting race and ethnicity have been made to the acute flaccid myelitis data collection form and will be implemented once the package is approved. We seek to use the modified version of “Race and Ethnicity Question with Minimum Categories Only”.

---

Authorizing Statute(s): US Code: 42 USC 241 Name of Law: Research and Investigations Generally
   US Code: 42 USC 301 Name of Law: General Powers and Duties of Public Health Service
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 35526	07/28/2025
30-day Notice:	Federal Register Citation:	Citation Date:
	91 FR 2358	01/20/2026
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 4

IC Title	Form No.	Form Name
Att D-1_CJD	0920-0009	CJD form
Att D-3_Reye Syndrome	0920-0009	Reye Syndrome form
Att D-4_Acute Flaccid Myelitis	0920-0009	Acute Flaccid Myelitis: Patient Summary Form
Att D2_Kawasaki Syndrome	0920-0009	Kawasaki Syndrome form

---

ICR Summary of Burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	181	461	0	-280	0	0
Annual Time Burden (Hours)	78	98	0	-20	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: This request is for 78 hours, which is a decrease of 20 hours since the last request of 98 hours.

---

Annual Cost to Federal Government: $10,000

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 01/21/2026

---